Accounts Receivable turnover ratio remained unchanged during the second quarter 2026, compared to the previous quarter at 4.83 indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Average collection period, for Abeona Therapeutics Inc 's accounts receivable remained unchanged at 76 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 448 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2721 to 3221.

What is Receivable Turnover Ratio?
What is Abeona Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ABEO Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	506.69 %	314.9 %	306.48 %	0.19 %	-0.61 %
Y / Y Revenue Change	697.48 %	669.01 %	581.04 %	40.62 %	19.82 %
Receivable Turnover Ratio (TTM)	4.83	4.83	3.93	3.34	3.04
ABEO's Total Ranking	# 3221	# 2721	# 2692	# 3449	# 2826
Accounts Receivable average collection period days	76	76	93	109	120
Seq. Receivable Change	47.4 %	-0.09 %	315.53 %	-0.86 %	0.8 %
Seq. Revenue Change	12.96 %	44.6 %	316.69 %	17.17 %	8.93 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 146
Healthcare Sector	# 449
Overall Market	# 3221

Receivable Turnover Ratio Statistics
High	Average	Low
2.12	0.42	0
(Mar 31 2013)		(Dec 31 2018)

ABEO Company Profile • Back to ABEO Efficiency Comparisons • Compare ABEO Receivables Turnover Ratio to its Competitors

Financial Statements
Abeona Therapeutics Inc 's Accounts Receivable	$ 10 Millions	Visit ABEO's Balance sheet
Abeona Therapeutics Inc 's Sales TTM	$ 30 Millions	Visit ABEO's Income Statement
Sources of ABEO's Revenues		Visit ABEO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ABEO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ABEO's Growth Rates	ABEO's Roa	ABEO's Inventory Turnover Ratio	ABEO's Dividend Comparisons
ABEO's Profitability Ratios	ABEO's Roi	ABEO's Asset Turnover Ratio	ABEO's Dividend Growth
ABEO's Valuation Ratios	ABEO's Roe	ABEO's Financial Strength Ratios	ABEO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Pulse Biosciences Inc	8.35	$ 1.185 Millions	$ 0.142 Millions
Alpha Teknova Inc	8.33	$ 43.407 Millions	$ 5.208 Millions
Rockwell Medical inc	8.31	$ 69.827 Millions	$ 8.400 Millions
Inspire Medical Systems inc	8.25	$ 899.227 Millions	$ 109.027 Millions
Sonoma Pharmaceuticals Inc	8.24	$ 21.920 Millions	$ 2.661 Millions
Madrigal Pharmaceuticals Inc	8.19	$ 1,283.940 Millions	$ 156.857 Millions
X4 Pharmaceuticals Inc	8.17	$ 9.441 Millions	$ 1.156 Millions
Seastar Medical Holding Corp	8.11	$ 1.713 Millions	$ 0.211 Millions
Atricure Inc	8.08	$ 567.747 Millions	$ 70.232 Millions
Concentra Group Holdings Parent Inc	8.07	$ 2,287.465 Millions	$ 283.300 Millions
Penumbra Inc	8.06	$ 1,504.874 Millions	$ 186.788 Millions
Sanuwave Health Inc	8.04	$ 43.903 Millions	$ 5.461 Millions
Sight Sciences Inc	8.04	$ 83.351 Millions	$ 10.368 Millions
Aveanna Healthcare Holdings Inc	8.03	$ 2,602.820 Millions	$ 324.026 Millions
Avita Medical Inc	7.99	$ 75.631 Millions	$ 9.463 Millions
Koru Medical Systems Inc	7.97	$ 45.108 Millions	$ 5.658 Millions
Alphatec Holdings Inc	7.94	$ 814.780 Millions	$ 102.662 Millions
Safe Pro Group Inc	7.94	$ 2.881 Millions	$ 0.363 Millions
Henry Schein Inc	7.91	$ 13,602.000 Millions	$ 1,719.000 Millions
Tela Bio Inc	7.86	$ 80.535 Millions	$ 10.243 Millions
Exelixis Inc	7.81	$ 2,435.920 Millions	$ 311.950 Millions
Castle Biosciences Inc	7.79	$ 357.278 Millions	$ 45.867 Millions
Trisalus Life Sciences Inc	7.78	$ 45.179 Millions	$ 5.808 Millions
Idexx Laboratories Inc	7.75	$ 4,553.792 Millions	$ 587.472 Millions
Vycor Medical Inc	7.68	$ 1.807 Millions	$ 0.235 Millions
Aurinia Pharmaceuticals Inc	7.67	$ 311.507 Millions	$ 40.624 Millions
Beta Bionics Inc	7.65	$ 119.513 Millions	$ 15.615 Millions
Lemaitre Vascular Inc	7.65	$ 262.923 Millions	$ 34.370 Millions
Novocure Limited	7.62	$ 699.193 Millions	$ 91.768 Millions
Natera Inc	7.61	$ 2,707.077 Millions	$ 355.618 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.